Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
TCT 2025: 10-Year Mortality in NOBLE: PCI vs CABG for Left Main Disease
Author(s): Evald Høj Christiansen Added: 5 months ago
TCT 2025 - 10-year findings from NOBLE showed no safety concerns for percutaneous coronary intervention (PCI) compared to coronary artery bypass surgery (CABG) for the treatment of left main coronary artery (LMCA) disease.Dr Evald Høj Christiansen (Aarhus University Hospital, Aarhus, DK) joins us to share the 10-year mortality findings from the NOBLE trial, investigating PCI vs CABG in LMCA… View more

Intervention

Prevention & Chronic Conditions
FLOW: Kidney, Cardiovascular, Mortality, Metabolic and Safety Results
Author(s): Richard Pratley Added: 1 year ago
EASD 24 - We are joined by Dr Richard Pratley (AdventHealth Diabetes Institute, US) to discuss the kidney, cardiovascular, metabolic, mortality and safety results from the FLOW trial.Interview Questions:1. What is the reasoning behind the FLOW Trial?2. What was the patient population and study design?3. What are the key results?4. Were there any surprising or unexpected findings?5. What further… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
TTR Therapies Show Delayed Mortality Benefit in ATTR-CM
Added: 1 month ago Source:  Radcliffe Cardiology
Therapies for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), including transthyretin (TTR) stabilisers and silencers, have demonstrated a mortality benefit in randomised trials. However, the timing of this benefit has been a subject of debate. A new analysis of three major outcomes trials has evaluated this time course, revealing a consistent pattern across different treatments… View more

Heart Failure
SCAI 25: Insights from the TRITAVI Registry
Author(s): Francesco Pelliccia Added: 11 months ago
SCAI 2025 - Insights from antiplatelet therapy after transcatheter aortic valve replacement (TAVR) show patients who received single antiplatelet treatment had significantly lower rates of overall six-month mortality, CV death and non-CV death compared to those treated with double antiplatelet treatment.Dr Francesco Pelliccia (Sapienza University of Rome, Rome, IT) joins us to discuss insights… View more

Anticoagulation

Intervention
PANDA II: In-hospital Influenza Vaccination Reduces Mortality and Readmission in Acute Heart Failure
Added: 7 months ago Source:  Radcliffe Cardiology
For patients hospitalised with acute heart failure, receiving an influenza vaccination prior to discharge can significantly lower the risk of all-cause mortality and subsequent hospital readmission over the following year. These findings come from the PANDA II trial, a large cluster-randomised study conducted in China.¹PANDA II was a pragmatic, multiregional, parallel-group, cluster-randomised,… View more

Heart Failure
TEER Linked to Better Outcomes in AFMR Patients
Added: 3 weeks ago Source:  Transcatheter Academy
A new study suggests that for elderly patients with atrial functional mitral regurgitation (AFMR), transcatheter edge-to-edge repair (TEER) is associated with a lower risk of mortality and heart failure hospitalisation compared with conventional medical therapy. The findings come from a propensity score-based comparison of two large Japanese registries, OCEAN-Mitral and REVEAL-AFMR… View more

Intervention

Demographic
ESC 25: The VICTOR & VICTORIA Pooled Analysis
Author(s): Javed Butler Added: 7 months ago
ESC Congress 2025 - Vericiguat significantly reduced risks of CV mortality and HF hospitalisations, as well as all-cause mortality across both the VICTOR and VICTORIA Trial.Dr JavedButler (Baylor Scott & White Health, Dallas, US) joins us to discuss findings from a pooled analysis of the recent VICTOR and VICTORIA trials, with data from 11155 participants with heart failure with reduced ejection… View more

Heart Failure
Hyperkalaemia in Acute Heart Failure: An Asian Population Study
Author(s): Wy Jin Quah , Maizatu Akma Sulong , Ghazali Ahmad , et al Added: 9 months ago

Cardiovascular Renal Metabolic

Heart Failure
Hospital Frailty Risk Score in Heart Failure
Author(s): Zhenwei Teo , Ying Zi Oh , Weiliang Huang , et al Added: 1 year ago

Guidelines & Statements

Heart Failure
Prognostic Value of HF Stratification and Cardiologist Follow-Up
Author(s): Guillaume Baudry Added: 10 months ago
ESC HF 25 - Findings from a French nationwide cohort study investigating cardiologist follow-up show greater reduction in all-cause mortality associated with annual cardiology hospital visits.Dr Guillaume Baudry (University Hospital of Brabois, Nancy, FR) discusses findings from a nationwide trial investigating the prognostic value of heart failure stratification and cardiologist follow-up in… View more

Heart Failure